Genpharmasec Limited (BOM:531592)
India
· Delayed Price · Currency is INR 2.120
+0.010 (0.47%)
At close: Jun 9, 2025
Genpharmasec Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
| Cash & Equivalents | 52.71 | 188.32 | 19.93 | 16.07 | 35.34 | Upgrade
|
| Short-Term Investments | - | 16.84 | 9.54 | 24.51 | 76.69 | Upgrade
|
| Trading Asset Securities | - | 12.6 | 7.09 | 18.83 | 31.19 | Upgrade
|
| Cash & Short-Term Investments | 52.71 | 217.76 | 36.56 | 59.41 | 143.21 | Upgrade
|
| Cash Growth | -75.79% | 495.68% | -38.47% | -58.52% | 194.49% | Upgrade
|
| Accounts Receivable | 135.96 | 91 | 57.09 | 64.48 | 75.25 | Upgrade
|
| Other Receivables | - | 0.49 | 0.08 | 2.64 | - | Upgrade
|
| Receivables | 144.47 | 91.56 | 61.98 | 73.92 | 75.25 | Upgrade
|
| Inventory | 81.98 | 75.82 | 89.77 | 80.21 | 45.62 | Upgrade
|
| Prepaid Expenses | - | - | 0.21 | 0.16 | 0.01 | Upgrade
|
| Other Current Assets | 2.41 | 24.6 | 0.77 | 1.75 | 3.72 | Upgrade
|
| Total Current Assets | 281.56 | 409.74 | 189.29 | 215.44 | 267.81 | Upgrade
|
| Property, Plant & Equipment | 75.83 | 8.39 | 1 | 1.04 | 0.48 | Upgrade
|
| Long-Term Investments | 188.37 | 176.4 | - | - | 1.38 | Upgrade
|
| Long-Term Deferred Tax Assets | 4.64 | 4.26 | 8.46 | 0.03 | 0.03 | Upgrade
|
| Other Long-Term Assets | 25.63 | - | - | - | 0.13 | Upgrade
|
| Total Assets | 798.92 | 711.26 | 198.75 | 216.5 | 278.2 | Upgrade
|
| Accounts Payable | 82.59 | 23.79 | 13.7 | 62.21 | 71.16 | Upgrade
|
| Accrued Expenses | - | 1.76 | 0.21 | 0.11 | 0.4 | Upgrade
|
| Short-Term Debt | - | - | 6.01 | - | - | Upgrade
|
| Current Portion of Leases | 5.18 | - | - | - | - | Upgrade
|
| Current Income Taxes Payable | 5.64 | - | - | - | 0.03 | Upgrade
|
| Other Current Liabilities | 4.95 | 1.47 | 0.72 | 0.49 | - | Upgrade
|
| Total Current Liabilities | 98.36 | 27.02 | 20.64 | 62.81 | 71.58 | Upgrade
|
| Long-Term Debt | 31.47 | 32.1 | 24.81 | - | - | Upgrade
|
| Long-Term Leases | 16.2 | 6.78 | - | - | - | Upgrade
|
| Other Long-Term Liabilities | 0.11 | - | - | 0 | - | Upgrade
|
| Total Liabilities | 146.13 | 65.91 | 45.45 | 62.81 | 71.58 | Upgrade
|
| Common Stock | 553.72 | 553.72 | 276.86 | 276.86 | 276.86 | Upgrade
|
| Additional Paid-In Capital | - | 207.65 | - | - | - | Upgrade
|
| Retained Earnings | - | -46.82 | -45.66 | -48.69 | 13.05 | Upgrade
|
| Comprehensive Income & Other | 97.91 | -70.59 | -77.89 | -74.47 | -83.3 | Upgrade
|
| Total Common Equity | 651.63 | 643.95 | 153.3 | 153.7 | 206.62 | Upgrade
|
| Minority Interest | 1.17 | 1.4 | - | - | - | Upgrade
|
| Shareholders' Equity | 652.8 | 645.35 | 153.3 | 153.7 | 206.62 | Upgrade
|
| Total Liabilities & Equity | 798.92 | 711.26 | 198.75 | 216.5 | 278.2 | Upgrade
|
| Total Debt | 52.85 | 38.89 | 30.82 | - | - | Upgrade
|
| Net Cash (Debt) | -0.13 | 178.87 | 5.74 | 59.41 | 143.21 | Upgrade
|
| Net Cash Growth | - | 3018.39% | -90.34% | -58.52% | 194.49% | Upgrade
|
| Net Cash Per Share | - | 0.58 | 0.02 | 0.21 | 0.53 | Upgrade
|
| Filing Date Shares Outstanding | - | 533.72 | 276.86 | 276.86 | 276.86 | Upgrade
|
| Total Common Shares Outstanding | - | 533.72 | 276.86 | 276.86 | 276.86 | Upgrade
|
| Working Capital | 183.21 | 382.72 | 168.66 | 152.63 | 196.23 | Upgrade
|
| Book Value Per Share | - | 1.21 | 0.55 | 0.56 | 0.75 | Upgrade
|
| Tangible Book Value | 651.63 | 643.95 | 153.3 | 153.7 | 206.62 | Upgrade
|
| Tangible Book Value Per Share | - | 1.21 | 0.55 | 0.56 | 0.75 | Upgrade
|
| Buildings | - | 0.69 | 0.69 | 0.69 | 0.22 | Upgrade
|
| Machinery | - | 1.02 | 0.84 | 0.68 | 0.46 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.